ACAD Financing Cash Flow
Acadia Pharmaceuticals Inc · Financing Cash Flow
ACAD Financing Cash Flow
Latest reported$51.05Mperiod ending
ACAD TTM Cash from Financing ($30.11M → $51.05M)
TTM financing cash flow
High-resolution chart · PNG
ACAD financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 51,045,000 | |
| 52,276,000 | |
| 49,883,000 | |
| 29,186,000 | |
| 20,031,000 | |
| 7,640,000 | |
| 6,845,000 | |
| 10,310,000 | |
| 22,793,000 | |
| 24,706,000 | |
| 25,129,000 | |
| 21,309,000 | |
| 8,845,000 | |
| 7,198,000 | |
| 8,199,000 | |
| 10,950,000 | |
| 11,729,000 | |
| 12,903,000 | |
| 18,162,000 | |
| 31,923,000 | |
| 42,572,000 | |
| 84,968,000 | |
| 80,996,000 | |
| 105,928,000 | |
| 414,180,000 | |
| 371,425,000 | |
| 371,847,000 | |
| 629,392,000 | |
| 309,636,000 | |
| 307,943,000 | |
| 306,647,000 | |
| 10,835,000 | |
| 18,521,000 | |
| 22,578,000 | |
| 31,188,000 | |
| 30,383,000 | |
| 248,563,000 | |
| 262,311,000 | |
| 533,812,000 | |
| 539,158,000 | |
| 314,213,000 | |
| 296,054,000 | |
| 14,502,000 | |
| 7,977,000 | |
| 8,127,000 | |
| 7,248,000 | |
| 203,851,000 | |
| 201,673,000 | |
| 201,365,000 | |
| 309,516,000 | |
| 111,682,000 | |
| 202,286,000 | |
| 208,172,000 | |
| 98,358,000 | |
| 98,172,000 | |
| 7,036,000 | |
| 166,000 | |
| 156,000 | |
| 13,944,000 | |
| 14,206,000 | |
| 14,534,000 | |
| 14,383,000 | |
| 470,000 | |
| 1,188,000 | |
| 1,260,000 | |
| 1,273,000 | |
| 1,161,000 | |
| -26,000 | |
| -634,000 | |
| -428,000 | |
| -374,000 | |
| -55,000 | |
| 86,000 | |
| 96,969,000 | |
| 98,220,000 | |
| 98,824,000 | |
| 99,358,000 | |
| 62,232,000 | |
| 69,996,000 | |
| 56,716,900 | |
| 56,509,900 | |
| 31,101,700 | |
| 28,370,200 | |
| 40,530,000 | |
| 39,937,900 | |
| 36,987,000 | |
| 30,106,400 |